Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells
Open Access
Abstract
The viral antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) derived from pluripotent stem cells (PSCs), i.e., PSC-CTLs, have the ability to suppress the human immunodeficiency virus (HIV) infection. After adoptive transfer, PSC-CTLs can infiltrate into the local tissues to suppress HIV replication. Nevertheless, the mechanisms by which the viral Ag-specific PSC-CTLs elicit the antiviral response remain to be fully elucidated. In this study, we generated the functional HIV-1 Gag epitope SL9-specific CTLs from the induced PSC (iPSCs), i.e., iPSC-CTLs, and investigated the suppression of SL9-specific iPSC-CTLs on viral replication and the protection of CD4+ T cells. A chimeric HIV-1, i.e., EcoHIV, was used to produce HIV replication in mice. We show that adoptive transfer of SL9-specific iPSC-CTLs greatly suppressed EcoHIV replication in the peritoneal macrophages and spleen in the animal model. Furthermore, we demonstrate that the adoptive transfer significantly reduced expression of PD-1 on CD4+ T cells in the spleen and generated persistent anti-HIV memory T cells. These results indicate that stem cell-derived viral Ag-specific CTLs can robustly accumulate in the local tissues to suppress HIV replication and prevent CD4+ T cell exhaustion through reduction of PD-1 expression.Keywords
Funding Information
- National Institutes of Health (R01AI121180, R01CA221867 and R21AI128325)
This publication has 38 references indexed in Scilit:
- HIV-1 infection and the lack of viral control are associated with greater expression of interleukin-21 receptor on CD8+ T cellsAIDS, 2021
- A Review of Current Strategies Towards the Elimination of Latent HIV-1 and Subsequent HIV-1 CureCurrent HIV Research, 2021
- Enhancement of HIV-1 Env-Specific CD8 T Cell Responses Using Interferon-Stimulated Gene 15 as an Immune AdjuvantJournal of Virology, 2020
- Haemopoietic cell transplantation in patients living with HIVThe Lancet HIV, 2020
- Immune effects of Lactobacillus casei Shirota in treated HIV-infected patients with poor CD4+ T-cell recoveryAIDS, 2020
- CD8+ T cells in HIV control, cure and preventionNature Reviews Immunology, 2020
- Effect of HIV infection and antiretroviral therapy on immune cellular functionsJCI Insight, 2019
- Follicular CXCR5-expressing CD8+ T cells curtail chronic viral infectionNature, 2016
- Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patientJournal of Hepatology, 2015
- Mutations in HIV-1 Reverse Transcriptase Affect the Errors Made in a Single Cycle of Viral ReplicationJournal of Virology, 2014